fbpx
December 17, 2021

Aducanumab for Alzheimer’s Gets Thumbs Down in Europe Aducanumab for Alzheimer’s Gets Thumbs Down in Europe

At its December meeting, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) rejected the controversial Alzheimer’s drug aducanumab (Aduhelm, […]
December 16, 2021

Tofacitinib Approved for New Ankylosing Spondylitis Indication Tofacitinib Approved for New Ankylosing Spondylitis Indication

The US Food and Drug Administration (FDA) approved a supplemental new drug application for tofacitinib (Xeljanz, Xeljanz XR) that adds active ankylosing spondylitis in adults to […]
December 15, 2021

FDA Approves Upadacitinib (Rinvoq) for Psoriatic Arthritis FDA Approves Upadacitinib (Rinvoq) for Psoriatic Arthritis

The US Food and Drug Administration has approved a 15-mg extended release tablet of upadacitinib (Rinvoq) for adults with psoriatic arthritis who had an inadequate response […]
December 13, 2021

Abrocitinib Approved for Atopic Dermatitis in Europe Abrocitinib Approved for Atopic Dermatitis in Europe

The oral Janus kinase 1 inhibitor abrocitinib has been approved in Europe for the treatment of moderate to severe atopic dermatitis (AD) in adults, who are […]
December 9, 2021

CDC, FDA Sign Off on Pfizer Boosters for 16- and 17-Year-Olds CDC, FDA Sign Off on Pfizer Boosters for 16- and 17-Year-Olds

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) authorized booster doses of Pfizer’s […]
December 9, 2021

AHA, AMA Sue Federal Government Over Surprise Billing Law AHA, AMA Sue Federal Government Over Surprise Billing Law

Hospital and physician groups on Thursday announced their plan to sue the federal government over its plan for addressing disputes about surprise medical bills, which tilts […]
December 6, 2021

Class I Recall of Percutaneous Thrombolytic Device Class I Recall of Percutaneous Thrombolytic Device

Arrow International Inc, a subsidiary of Teleflex, has recalled a total of 3241 Arrow-Trerotola over-the-wire 7FR percutaneous thrombolytic device (PTD) kits because of the risk of […]
December 3, 2021

FDA Approves Rituximab for Multiple Pediatric Cancers FDA Approves Rituximab for Multiple Pediatric Cancers

The US Food and Drug Administration yesterday approved rituximab (Rituxan) in combination with chemotherapy for pediatric patients (age 6 months to <18 years) with previously untreated, advanced stage, […]
December 1, 2021

FDA Approves Time-Saving Combo for R/r Multiple Myeloma FDA Approves Time-Saving Combo for R/r Multiple Myeloma

The US Food and Drug Administration (FDA) this week approved daratumumab + hyaluronidase-fihj (Darzalex Faspro) and carfilzomib (Kyprolis) plus dexamethasone (Kd) for patients with relapsed or […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0